PDGFRA and glioblastoma: However, the simultaneous inhibition of PDGFRA and EphA2 suppressed GBM cell growth in vitro and in vivo, thus encouraging clinical studies to be carried out targeting EphA2 protein in GBM treatment (Table 3).